Dianthus Therapeutics, Inc. (DNTH)
DNTH price $78.13 -0.62 -0.79%
- Ticker
- DNTH
- Price
- $78.13
- Change
- -0.62 -0.79%
- Market cap
- $4.37B
- P/E
- -605.77
- Forward P/E
- 27.19
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 45
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid…